Clinical Trial Update: Implementation and Delivery of Cabotegravir Long Acting Injection for PrEP in a Community Pharmacy Setting.

View source ↗

Summary

A completed study assessed the implementation and delivery of cabotegravir long-acting injections for PrEP in a community pharmacy setting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• APRETUDE (CABOTEGRAVIR)

Snippet

Sponsor: Kelley-Ross & Associates, Inc. | Conditions: HIV Infections | Status: COMPLETED